Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for characterizing Microsatellite Instability in Persian Lynch Syndrome patients
Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for characterizing Microsatellite Instability in Persian Lynch Syndrome patients
Najmeh Farahani1 Parvaneh Nikpour2 Mohammad Hassan Emami3 Morteza Hashemzadeh4 Mehrdad Zeinalian5 Seyed Shervin Shariatpanahi6 Rasoul Salehi7
1) Isfahan University of Medical Sciences
2) Isfahan University of Medical Sciences
3) Isfahan University of Medical Sciences
4) Shahrekord University of Medical Sciences
5) Shahrekord University of Medical Sciences
6) Isfahan University of Medical Sciences
7) Isfahan University of Medical Sciences
IOI Code
:
XYAH-ZDAFB
Publication :
3rd international conference of Science and Engineering(3icesconf.com)
Abstract :
Background Colorectal malignancies with high microsatellite instability (MSI-H), either hereditary (Lynch syndrome) or sporadic, demonstrate better prognosis, altered response to 5FU chemotherapy and altered operative approach. It is now recommended to perform MSI testing for all new cases of colorectal cancer regardless of being categorized as hereditary or sporadic. For MSI detection, immunohistochemistry or PCR-based protocols using a cohort of various sets of STR markers are recommended. Here we aimed to evaluate a simplified protocol using just a single STR marker, MT1XT20 mononucleotide repeat, for detection of MSI in Lynch syndrome patients. Promega five- marker MSI testing panel and Immunohistochemistry used as gold standard in conjunction of MT1XT20.
Methods Colorectal patients with positive history of familial cancers were sorted out by evaluating their medical records. Based on Amsterdam II criteria for Lynch syndrome 20 families were short listed. DNA extracted from the formalin fixed paraffin embedded tissues and their adjacent normal tissues resected from the index case in each family. Extracted DNA was subjected to MT1XT20 mononucleotide marker and commercially available five markers MSI testing kit (Promega, USA). IHC also was performed on tissue sections and the results were compared with PCR based techniques.
Results Eight (40%), seven (35%) and five (25%) cases were MSI positive using Promega kit, IHC and MT1XT20 respectively. Among the markers included in Promega kit, BAT26 marker showed instability in all 8 samples was the most instable marker (100%). NR24 and NR21 markers showed instability in 7 cases (87.5%), BAT25 and MONO 27 markers were instable in 6 (75%) and 5 (62.5%) specimens respectively.
Conclusion Although MT1XT20 as standalone marker has already reported as valid single marker for MSI testing in CRC patients, but we couldn’t verify this in Iranian patients. Instead BAT26 among the markers included in Promega MSI testing kit was shown instability in all 8 MSI-H CRC samples. Therefore, it seems BAT26 could act well as a single marker for MSI testing in Iranian CRC patients.
Keywords : lynch syndrome msi ihc mt1xt20 quasi monomorphic repeats